Loading...
Internationally Recognized Certificates of Compliance (IRCC)
  |  
last updated: 19 Sep 2019
General Information
ABSCH-IRCC-IN-247615-1
- Competent National Authority: | ABSCH-CNA-IN-202013-2
Competent National Authority:
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113, India
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Details of the permit or its equivalent
India/NBA/Appl/9/1541
Application in Form-III for seeking approval for the invention on "A process for the extraction and purification of tetrandrine" for obtaining IP Rights in India 

Indian Patent Application Number: 201741016069  Date of Filing: 2017-05-08


21 Nov 2017
Prior Informed Consent (PIC) Information
Yes
- Competent National Authority: | ABSCH-CNA-IN-202013-2
Competent National Authority:
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113, India
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Confidential information
- Person: Dr Bhagya Nekrakalaya | ABSCH-CON-IN-239996-1
Person:
Dr Bhagya Nekrakalaya
Nilaya Madhur, Bedradka,
Kasaragod, Kerala
671 124, India
Phone: +91 9986795459,
Fax:
Website:
Confidential information
Mutually Agreed Terms (MAT) Information
Yes
1. The user shall notify the NBA within 60 days from the date of grant of IPR.
2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus government taxes. 
3. The user shall inform the NBA about any commercialization made on the IP Rights granted.
4. The user shall submit annual report to NBA as per the terms and conditions agreed upon.  


Subject-matter or genetic resource(s)
For obtaining IP Rights on the Invention “ A process for the extraction and purification of tetrandrine" in India

Biological Resources:

Patha - Cyclea peltata Lam Hook F Thomson (root)

Confidential information
Information on the utilization of the genetic resource(s)
  • Commercial
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee. 

2. In case the user assigns or transfer the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument which shall be binding upon such person.   
Additional Information
Amendment history
Unique identifier Status Date
ABSCH-IRCC-IN-247615-1
REVOKED OLD VERSION PUBLISHED DELETED
Sujata Arora (sujata@nic.in)
19 Sep 2019 09:31
on 19 Sep 2019 09:31